Independent intelligence for the laboratory world

PHC Launches Next-Generation PATHFAST Analyzer in Europe

PHC has launched its next-generation PATHFAST chemiluminescent immunoassay analyzer in Europe under the IVDR framework.

Press release summary

PHC Corp. launched its next-generation PATHFAST chemiluminescent immunoassay analyzer in Europe on Oct. 1. The company says the system is compliant with the European Unionโ€™s In Vitro Diagnostic Regulation and can produce results in as little as 17 minutes, depending on the assay.

The analyzer is designed to work with whole blood, plasma or serum as permitted by each assay. Its single-use reagent cartridges contain the required reagents and collect waste after testing, an approach intended to simplify handling and reduce exposure. PHC said the available menu includes biomarkers used in the assessment of myocardial infarction and sepsis. The model was introduced in Japan in October 2025, and the broader PATHFAST platform is used in about 50 countries.

Why it matters for laboratories

Rapid immunoassay testing can support shorter turnaround times in emergency, acute-care and near-patient settings while also affecting staffing, sample routing and biosafety workflows. European laboratories considering the analyzer should review the locally available assay menu, throughput, quality-control requirements and connectivity with existing laboratory information systems. Vendor-reported turnaround times and performance claims also require verification under each laboratoryโ€™s intended use and regulatory procedures.

Original source: PHC announcement.

Join the Discussion

Share your experience or ask a question about this article. Please keep comments relevant and respectful.

Leave a Reply

Your email address will not be published. Required fields are marked *